# LEQSELVI

NDC: 47335-108
Generic name: deuruxolitinib phosphate
Labeler / Manufacturer: Sun Pharmaceutical Industries, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20250625

FDA application: NDA217900

## Active ingredients

- DEURUXOLITINIB PHOSPHATE: 8 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"47335-108"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=47335-108
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=a603f231-d09e-4bad-ad5e-b55f865da095